AwardedCzechiaGoodsCZK 11,166,000
Antivirotika pro systémové použití – HBV - Vemlidy I.
- Published
- Published 6 February 2025
- Deadline
- Closed 11 March 2025
Overview
Předmětem veřejné zakázky jsou dodávky léčivého přípravku s obsahem účinné látky tenofovir-alafenamid (ATC J05AF13) pro léčbu pacientů ve schválených indikacích dle SPC platného ke dni podání nabídek. Předmět této VZ je určen pro nativní pacienty a switch pacienty dosud léčenými referenčním léčivým přípravkem s obsahem účinné látky tenofovir-disoproxil.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 11,166,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 6 February 2025
- Deadline
- Closed
Antivirals for systemic use
Award outcome
- Awarded value
- CZK 11,165,504
- Award date
- 14 March 2025
- Contract period
- 1 May 2025 → 10 April 2029
- Gilead Sciences s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
11 April 2025
Contract Notice
6 February 2025
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.